Abstract
Proliferation of the Friend retrovirus was specifically inhibited by the env mRNA complementary oligonucleotide encapsulated in pH-sensitive liposomes. This observation was made using the focus immunoassay (FIA) and the reverse transcriptase test. The key finding of the present study was the dramatic impact on liposome penetration. For chronic or de novo infection, the point at which the penetration of liposomes began corresponded to the time needed for the virus to leave the cell. In the absence of the virus, liposomes remained adsorbed onto the cell surface without any internalization. Regardless of the mechanism involved, the fact that a retroviral infection stimulates the cellular uptake of oligonucleotide liposomes widens the spectrum of strategies for specific antiviral action.
Similar content being viewed by others
REFERENCES
P. Zamecnik and M. L. Stephenson. Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxyribonucleotide. Proc. Natl. Acad. Sci. USA 75:280–284 (1978).
M. L. Stephenson and P. Zamecnik. Inhibition of Rous sarcoma virus RNA translation. Proc. Natl. Acad. Sci. USA 75:285–288 (1978).
E. L. Wickstrom. Olygodeoxyribonucleotide stability in subcellular extracts and culture media. J. Biochem. Biophys. Methods 13:97–102 (1986).
P. S. Miller, K. N. Fang, N. S. Kondo, and P. Ts'O. Synthesis and adenine and thymine nucleoside alkylphosphotriesters, the neutral analog of dinucleoside monophosphate. Biochemistry 18:5134–5144 (1979).
F. Eckstein. Nucleosides phosphorothioates. Annu. Rev. Biochem. 54:367–402 (1985).
M. Lemaître, B. Bayard, and B. Lebleu. Specific antiviral activity of a poly L lysine conjugated oligodeoxyribonucleotide sequence complementary to V.S.V. N protein mRNA initiation site. Proc. Natl. Acad. Sci. USA 84:648–652 (1987).
U. Asseline, M. Delarue, G. Lancelot, N. T. Thuong, T. Montenay-Garestier, and C. Hélène. Nucleic acid-binding with high affinity and base sequence specificity: Intercalating agents covalently linked to oligodeoxyribonucleotides. Proc. Natl. Acad. Sci. USA 81:3297–3301 (1984).
C. Chavany, T. Le Doan, P. Couvreur, F. Puisieux, and C. Hélène. Polyalkylcyanoacrylate nanoparticles as polymeric carriers for antisense oligonucleotides. Pharm. Res. 9:000–000 (1992).
J. P. Leonetti, P. Machy, G. Degols, B. Lebleu, and L. Leserman. Antibody targeted liposomes containing oligodeoxynucleotide complementary to viral RNA selectively inhibit viral replication. Proc. Natl. Acad. Sci. USA 87:2448–2451 (1990).
F. C. Svoka. In K. Yagi (ed.), Medical Application of Liposomes, Japan Scientific Society Press, Tokyo, 1986, pp. 21–30.
D. Collins, F. Maxfield, and L. Huang. Immunoliposomes with different acid sensitivities as probes for the cellular endocytic pathway. Biochim. Biophys. Acta 987:47–55 (1989).
C. J. Chu, J. Dijkstra, M. Z. Lai, K. Hong, and F. C. Szoka. Efficiency of cytoplasmic delivery by pH sensitive liposomes to cells in culture. Pharm. Res. 7:000–000 (1990).
C. Ropert, M. Lavignon, C. Dubernet, P. Couvreur, and C. Malvy. Oligonucleotides encapsulated in pH sensitive liposomes are efficient toward Friend retrovirus. Biochem. Biophys. Res. Comm. 183 (2):879–889 (1992).
F. Szoka and P. Papahadjopoulos. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse phase evaporation. Proc. Natl. Acad. Sci. 75 (9):4194–4198 (1978).
M. Sitbon, J. Nishio, K. Wehrly, D. Lodmell, and B. Chesebro. Use of a focal immunofluorescence assay on live cells for quantification of retroviruses: Distinction of host range classes in virus mixtures and biological cloning of dualtropic murine leukemia viruses. Virology 141:110–118 (1985).
B. Chesebro, F. Wehrly, M. Cloyd, W. Britt, J. Portis, J. Collins, and J. Nishio. Characterization of mouse monoclonal antibodies specific for Friend murine leukemia virus-induced erythroleukemia cells: Friend-specific and FMR-specific antigens. Virology 112:131–134 (1981).
S. Akthar, S. Basu, E. Wickstrom, and R. L. Juliano. Interaction of antisense oligonucleotides analogs with phospholipid membranes (liposomes). Nucleic Acid. Res. 20 (19):5551–5559 (1991).
M. Vasseur. In Les virus oncogènes, Hermann, Paris, 1989.
A. Willer, K. Buff, F. D. Goebel, and V. Erfle. HIV-1, induced membranes alterations increase susceptibility to cytolysis by lipid formulations. IVth Intl. Conf. AIDS, Stockholm, 1988; Abstr. No. 3535.
K. Apostolov, W. Barker, S. A. Galpin, N. A. Habib, C. B. Wood, and D. Kinchington. Syncitia formation in HIV 1 infected cells is associated with an increase in cellular oleic acid. Febs. Lett. 250:241–244 (1989).
J. P. Leonetti, N. Mechti, G. Degols, C. Gagnor, and B. Lebleu. Intracellular distribution of microinjected antisense oligonucleotides. Proc. Natl. Acad. Sci. USA 88:2702–2706 (1991).
D. J. Chin, G. A. Green, G. Zon, F. C. Szoka, and R. M. Straubinger. Rapid nuclear accumulation of injected deoxyribonucleotides. New Biol. 2:1091–1100 (1990).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ropert, C., Malvy, C. & Couvreur, P. Inhibition of the Friend Retrovirus by Antisense Oligonucleotides Encapsulated in Liposomes: Mechanism of Action. Pharm Res 10, 1427–1433 (1993). https://doi.org/10.1023/A:1018910922633
Issue Date:
DOI: https://doi.org/10.1023/A:1018910922633